Published in J Neurovirol on July 18, 2016
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22
Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol (2007) 3.05
The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. Psychol Med (1997) 2.74
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry (1988) 2.36
Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res (2000) 1.87
Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol (2004) 1.85
Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res (1996) 1.81
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med (2014) 1.75
Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol (2007) 1.73
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64
Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest (2006) 1.58
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis. Rev Bras Psiquiatr (2014) 1.50
Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry (1997) 1.34
Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. J Clin Exp Neuropsychol (2006) 1.08
Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett (2007) 1.07
Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. J Neurovirol (2013) 1.05
Depression in women living with HIV: clinical and psychosocial correlates. Arch Womens Ment Health (2009) 1.04
Increased risk of suicide attempts among Black and Latino lesbians, gay men, and bisexuals. Am J Public Health (2011) 1.03
The influence of depression on the progression of HIV: direct and indirect effects. Behav Modif (2011) 0.95
Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neurovirol (2013) 0.92
The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol (2000) 0.92
Molecular epidemiology of HIV-1 clades in Southern Brazil. Mem Inst Oswaldo Cruz (2010) 0.89
Depression in HIV-infected patients: allopathic, complementary, and alternative treatments. J Psychosom Res (2004) 0.89
Through a glass, darkly: cerebrospinal fluid viral load measurements and the pathogenesis of human immunodeficiency virus infection of the central nervous system. Arch Neurol (2002) 0.86
Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil. J Affect Disord (2012) 0.85
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study. J Neurovirol (2016) 0.84
High prevalence of suicide risk in people living with HIV: who is at higher risk? AIDS Care (2014) 0.83
Frequency of depression among patients with neurocysticercosis. Arq Neuropsiquiatr (2010) 0.83
Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy. Rev Bras Psiquiatr (2012) 0.83
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis (2014) 0.82
A study of neuropsychiatric manifestations in patients of neurocysticercosis. Indian J Psychiatry (2013) 0.81
Associations among depression, suicidal behavior, and quality of life in patients with human immunodeficiency virus. World J Virol (2015) 0.79
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
[Depression in HIV infection: prevalence, risk factors and management]. Rev Chilena Infectol (2010) 0.77
Drug treatment of depression in HIV-positive patients : safety considerations. Drug Saf (2005) 0.76
Interleukin levels in cerebrospinal fluid from children with neurocysticercosis. Am J Trop Med Hyg (2001) 0.76
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc (2004) 6.64
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol (2004) 4.90
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc (2004) 3.21
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol (2004) 3.12
Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS (2005) 2.25
Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol (2004) 2.22
Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS (2006) 2.13
Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol (2011) 2.06
Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol (2007) 2.03
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (2002) 1.78
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol (2011) 1.73
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol (2005) 1.62
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol (2006) 1.33
Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology (2006) 1.23
Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol (2008) 1.23
Lithium improves HIV-associated neurocognitive impairment. AIDS (2006) 1.16
Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc (2007) 1.12
APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS (2010) 1.12
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend (2009) 1.08
Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol (2009) 1.06
Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV. J Affect Disord (2009) 1.04
Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol (2005) 1.04
Semantic clustering inefficiency in HIV-associated dementia. J Neuropsychiatry Clin Neurosci (2007) 1.02
The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol (2007) 1.01
Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol (2007) 0.99
The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol (2004) 0.95
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology (2008) 0.94
AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS (2001) 0.92
Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc (2010) 0.88
Temperament and risky behaviors: a pathway to HIV? J Affect Disord (2005) 0.87
Valproic acid does not affect markers of human immunodeficiency virus disease progression. J Neurovirol (2006) 0.86
Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res (2010) 0.83
Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J Neurovirol (2007) 0.83
The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era. Ocul Immunol Inflamm (2004) 0.80
The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China. PLoS One (2012) 0.80
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance. Virology (2009) 0.79
Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning. J Int Neuropsychol Soc (2010) 0.79
Cerebrospinal fluid can be used for HIV genotyping when it fails in blood. Arq Neuropsiquiatr (2014) 0.78
Second-language fluency predicts native language stroop effects: evidence from Spanish-English bilinguals. J Int Neuropsychol Soc (2014) 0.78
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - method-comparison evaluations. Arq Neuropsiquiatr (2014) 0.75
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75